SCHEMBL1259205

SCHEMBL1259205

O=CNCn1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4042725 0.80 DAO (0.38)
SCHEMBL7771685 0.80 FDPS (0.41)
SCHEMBL6007415 0.79
SCHEMBL1778746 0.72
SCHEMBL2405207 0.71
SCHEMBL1680469 0.71
SCHEMBL1186227 0.71 FDPS (0.36)
SCHEMBL20024586 0.71 HDAC1 (0.40)
SCHEMBL8187886 0.69 FDPS (0.42)
SCHEMBL8105773 0.69 DAO (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219954-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ASANA BIOSCIENCES, LLC 2023-07-13 US claimed
US-11685736-B2 P2X3 and/or P2X2/3 compounds and methods ABS DEVELOPMENT 1, INC. (US) 2023-06-27 US claimed
EP-3083619-B1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ASANA BIOSCIENCES LLC (US) 2021-11-03 EP claimed
US-20200109143-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ABS DEVELOPMENT 1, INC. 2020-04-09 US claimed
US-10544145-B2 P2X3 and/or P2X2/3 compounds and methods ASANA BIOSCIENCES, LLC (US) 2020-01-28 US claimed
US-20190248789-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ABS DEVELOPMENT 1, INC. 2019-08-15 US claimed
US-20180186793-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ABS DEVELOPMENT 1, INC. 2018-07-05 US claimed
US-20160318927-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ASANA BIOSCIENCES, LLC (US) 2016-11-03 US claimed
EP-3083619-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS Asana BioSciences, LLC (US) 2016-10-26 EP claimed
EP-2785697-B1 N-(1H-PYRAZOLYL-METHYL) FORMAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS NITRIFICATION INHIBITORS PIESTERITZ STICKSTOFF (DE) 2016-02-03 EP claimed
WO-2015095128-A1 P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS ASANA BIOSCIENCES, LLC (US) 2015-06-25 WO claimed
EP-2785697-A1 N-(1H-PYRAZOLYLMETHYL)FORMAMIDES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF AS NITRIFICATION INHIBITORS SKW Stickstoffwerke Piesteritz GmbH (DE) 2014-10-08 EP claimed
WO-2013079197-A1 N-(1H-PYRAZOLYLMETHYL)FORMAMIDES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF AS NITRIFICATION INHIBITORS SKW STICKSTOFFWERKE PIESTERITZ GMBH (DE) 2013-06-06 WO claimed
WO-2025223971-A1 AMPHIPHILIC POLYACETAL BLOCK COPOLYMERS, THEIR PRODUCTION, AND THEIR USE IN AGROCHEMICAL PRODUCTS AND AGROCHEMICAL FORMULATIONS BASF SE (DE) 2025-10-30 WO disclosed
WO-2024126271-A1 BIODEGRADABLE GRAFT POLYMERS, THEIR PRODUCTION, AND THEIR USE IN AGROCHEMICAL FORMULATIONS BASF SE (DE) 2024-06-20 WO disclosed
EP-4384008-A1 AGROCHEMICAL COMPOSITION BASF SE (DE) 2024-06-19 EP disclosed
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
US-20040053923-A1 Novel isoindole derivatives BANYU PHARMACEUTICAL CO., LTD. 2004-03-18 US disclosed
US-6608098-B1 Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-08-19 US disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed